Hansa Biopharma Hosts Virtual Event on Transplant Surgery and Im lifidase Phase 3 Results
Hansa Biopharma AB announced a virtual event featuring distinguished transplant surgeons to discuss clinical practice and imlifidase Phase 3 results.
The event will feature Professor Robert Montgomery from NYU Langone Transplant Institute and Professor Matthew Cooper from the Medical College of Wisconsin, providing insights into the medical journey of highly sensitized patients awaiting a kidney transplant.
- Date: Wednesday, 12 November 2025
- Time: 9:00 AM EST / 15:00 PM CET
No additional quotes available.
Author: Hansa Biopharma AB hosts virtual event.
More News
- Quick start, steady goaltending propel Sharks to first home win of season
- Student death remains the routine at Middlebury - The Middlebury Campus
- Honor of Kings celebrates global culture with a new original skin series inspired by folklore
- ANZ flags $1.1b hit; Atlassian CFO exits; From prince to pauper
- Editorial: Movable bike barrier a good step for Richmond Bridge
- The End of Eurobike? Who Will Lead the Bike Industry Now?
- The Rise of the Populist Moderates
- Highlight Reel for 10/31 – The Bowdoin Orient
- Sharks score 3 straight to open 1st period, cruise past Devils | NHL.com
- QUICK RECAP: Devils 2 at Sharks 5 | New Jersey Devils